跳至主要内容
临床试验/DRKS00029743
DRKS00029743招募中未知

Rhythmic embrocation of the feet according to Wegman/ Hauschka to decrease the symptoms of chemotherapy-induced polyneuropathy

Medizinische Hochschule Hannover (MHH), Klinik für Strahlentherapie, OE 82400 个研究点目标入组 48 人开始时间: 2022年8月8日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
48

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 95 Years(—)
性别
All

入选标准

  • 18-95 years, diagnosis of oncologic disease and symptoms of chemotherapy-induced polyneuropathy (CIPN), patient consent, patients have received at least one course of platinum-, taxane-, or vincaloid-based chemotherapy, proteasome inhibitor, or thalidomide/lenalidomide/pomalidomide therapy, indication of at least. 4 points on the Numeric Rating Scale (NRS) for pain, cramps, tingling, or numbness in the feet (score: =4/10), platelet count greater than 100,000/µL

排除标准

  • According to the inclusion criteria, patients with polyneuropathy already before oncological system therapy, platelets<100,000/µl.
  • Psychological restrictions (lack of capacity to consent), which do not allow participation in the study.
  • Interventions such as massages/ rubs with or without oils during the study period.
  • Infections and/or open wounds on the feet, coagulopathies, allergy to the base oil, other neuropathies such as diabetic polyneuropathy

研究者

发起方
Medizinische Hochschule Hannover (MHH), Klinik für Strahlentherapie, OE 8240

相似试验